Embotrap
Device Neurovascular
PDI 10886704084570
General payments
$748,259
Research payments
$10,247
Through program year 2025, $748,259 in general payments and $10,247 in research payments were reported against Embotrap (Neurovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $69,689 | 858 |
| 2025 | Research | $10,247 | 2 |
| 2024 | General | $130,380 | 1,334 |
| 2023 | General | $373,081 | 1,304 |
| 2022 | General | $107,352 | 941 |
| 2021 | General | $67,757 | 546 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,983 general · 2 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.